• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿脑肿瘤微环境的免疫生物学与细胞因子调节:一项范围综述

Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review.

作者信息

Budhiraja Shreya, Najem Hinda, Tripathi Shashwat, Wadhawani Nitin R, Horbinski Craig, McCord Matthew, Lenzen Alicia C, Heimberger Amy B, DeCuypere Michael

机构信息

Division of Pediatric Neurosurgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.

Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

出版信息

Cancers (Basel). 2023 Jul 18;15(14):3655. doi: 10.3390/cancers15143655.

DOI:10.3390/cancers15143655
PMID:37509316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10377457/
Abstract

Utilizing a Scoping Review strategy in the domain of immune biology to identify immune therapeutic targets, knowledge gaps for implementing immune therapeutic strategies for pediatric brain tumors was assessed. The analysis demonstrated limited efforts to date to characterize and understand the immunological aspects of tumor biology with an over-reliance on observations from the adult glioma population. Foundational knowledge regarding the frequency and ubiquity of immune therapeutic targets is an area of unmet need along with the development of immune-competent pediatric tumor models to test therapeutics and especially combinatorial treatment. Opportunities arise in the evolution of pediatric tumor classification from histological to molecular with targeted immune therapeutics.

摘要

利用免疫生物学领域的范围综述策略来识别免疫治疗靶点,评估了实施小儿脑肿瘤免疫治疗策略的知识差距。分析表明,迄今为止,在表征和理解肿瘤生物学的免疫学方面所做的努力有限,过度依赖于来自成人胶质瘤人群的观察结果。关于免疫治疗靶点的频率和普遍性的基础知识是一个未满足的需求领域,同时还需要开发具有免疫活性的小儿肿瘤模型来测试治疗方法,尤其是联合治疗。随着小儿肿瘤分类从组织学向分子学发展以及靶向免疫治疗的出现,机遇也随之而来。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4883/10377457/1b8b6302bdf9/cancers-15-03655-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4883/10377457/b0c3d02560da/cancers-15-03655-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4883/10377457/cb676890b688/cancers-15-03655-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4883/10377457/1b8b6302bdf9/cancers-15-03655-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4883/10377457/b0c3d02560da/cancers-15-03655-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4883/10377457/cb676890b688/cancers-15-03655-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4883/10377457/1b8b6302bdf9/cancers-15-03655-g003.jpg

相似文献

1
Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review.小儿脑肿瘤微环境的免疫生物学与细胞因子调节:一项范围综述
Cancers (Basel). 2023 Jul 18;15(14):3655. doi: 10.3390/cancers15143655.
2
Pediatric gliomas immunity challenges and immunotherapy advances.小儿胶质瘤的免疫挑战与免疫治疗进展
Cancer Lett. 2025 May 28;618:217640. doi: 10.1016/j.canlet.2025.217640. Epub 2025 Mar 14.
3
Immune Microenvironment in Childhood Cancers: Characteristics and Therapeutic Challenges.儿童癌症中的免疫微环境:特征与治疗挑战
Cancers (Basel). 2024 Jun 12;16(12):2201. doi: 10.3390/cancers16122201.
4
Unveiling the landscape of cytokine research in glioma immunotherapy: a scientometrics analysis.揭示胶质瘤免疫治疗中细胞因子研究的全景:一项科学计量学分析。
Front Pharmacol. 2024 Jan 8;14:1333124. doi: 10.3389/fphar.2023.1333124. eCollection 2023.
5
Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.胶质母细胞瘤(GBM)有效治疗的组合方法:现状和未来前景。
Int Rev Immunol. 2022;41(6):582-605. doi: 10.1080/08830185.2022.2101647. Epub 2022 Aug 8.
6
Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy.中枢神经系统肿瘤的免疫微环境景观及其对免疫治疗反应的作用。
Cells. 2021 Aug 9;10(8):2032. doi: 10.3390/cells10082032.
7
Pediatric Glioma Models Provide Insights into Tumor Development and Future Therapeutic Strategies.小儿神经胶质瘤模型为肿瘤发生发展和未来治疗策略提供了新视角。
Dev Neurosci. 2024;46(1):22-43. doi: 10.1159/000531040. Epub 2023 May 12.
8
Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.儿科脑肿瘤:分子诊断、靶向和免疫治疗时代,以及对长期神经后遗症的关注。
Curr Probl Cancer. 2021 Aug;45(4):100777. doi: 10.1016/j.currproblcancer.2021.100777. Epub 2021 Jul 16.
9
Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma.弥漫性中线胶质瘤的免疫微环境及新兴免疫疗法的研究现状。
EBioMedicine. 2021 Jul;69:103453. doi: 10.1016/j.ebiom.2021.103453. Epub 2021 Jun 19.
10
The unique immune ecosystems in pediatric brain tumors: integrating single-cell and bulk RNA-sequencing.儿科脑肿瘤中的独特免疫生态系统:整合单细胞和批量 RNA 测序。
Front Immunol. 2023 Nov 29;14:1238684. doi: 10.3389/fimmu.2023.1238684. eCollection 2023.

引用本文的文献

1
Pediatric brain tumor patients display altered immune activation and reduced lymphopoiesis at the onset of disease.小儿脑肿瘤患者在疾病发作时表现出免疫激活改变和淋巴细胞生成减少。
NPJ Precis Oncol. 2024 Nov 20;8(1):269. doi: 10.1038/s41698-024-00755-y.
2
OV Modulators of the Paediatric Brain TIME: Current Status, Combination Strategies, Limitations and Future Directions.儿科大脑中的 OV 调节剂:当前状态、联合策略、局限性和未来方向。
Int J Mol Sci. 2024 May 3;25(9):5007. doi: 10.3390/ijms25095007.

本文引用的文献

1
Multi-institution analysis of tumor mutational burden and outcomes in pediatric central nervous system tumor patients.多机构分析儿童中枢神经系统肿瘤患者的肿瘤突变负担与结局。
Pediatr Blood Cancer. 2023 Mar;70(3):e30139. doi: 10.1002/pbc.30139. Epub 2022 Dec 26.
2
Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape.针对脑胶质瘤的肿瘤相关巨噬细胞免疫治疗:探索临床与转化研究领域。
Front Immunol. 2022 Oct 13;13:1024921. doi: 10.3389/fimmu.2022.1024921. eCollection 2022.
3
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.
溶瘤病毒 DNX-2401 治疗儿童弥漫性内在脑桥胶质瘤。
N Engl J Med. 2022 Jun 30;386(26):2471-2481. doi: 10.1056/NEJMoa2202028.
4
Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibition.表观遗传沉默信号调节蛋白(STING)在胶质瘤中具有发育保守性,并且可以通过甲基转移酶抑制作用得到挽救。
Cancer Cell. 2022 May 9;40(5):439-440. doi: 10.1016/j.ccell.2022.04.009. Epub 2022 Apr 28.
5
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression.中枢神经系统免疫互作组是癌症谱系、肿瘤微环境和 STAT3 表达的功能。
JCI Insight. 2022 May 9;7(9):e157612. doi: 10.1172/jci.insight.157612.
6
Notch signaling and natural killer cell infiltration in tumor tissues underlie medulloblastoma prognosis.Notch 信号通路和肿瘤组织中自然杀伤细胞浸润与髓母细胞瘤的预后相关。
Sci Rep. 2021 Dec 2;11(1):23282. doi: 10.1038/s41598-021-02651-y.
7
Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma. Toll 样受体及其在胶质瘤免疫治疗中的靶向作用
J Hematol Oncol. 2021 Oct 29;14(1):176. doi: 10.1186/s13045-021-01191-2.
8
High expression of Toll-like receptor 7 is a survival factor in pediatric medulloblastoma.Toll 样受体 7 的高表达是小儿髓母细胞瘤的生存因素。
Childs Nerv Syst. 2021 Dec;37(12):3743-3752. doi: 10.1007/s00381-021-05347-w. Epub 2021 Sep 4.
9
Damage-associated molecular patterns and Toll-like receptors in the tumor immune microenvironment.肿瘤免疫微环境中的损伤相关分子模式和 Toll 样受体。
Int Immunol. 2021 Nov 25;33(12):841-846. doi: 10.1093/intimm/dxab050.
10
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.